Advanced search
Companies (1253)
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urologi ...
Capitalization | 64 700 M USD |
---|---|
Change | +0.52% |
1-year price change | -7.34% |
Hannover Rück SE is a world leader in reinsurance. Gross written premiums break down by activity as follows: - non-life reinsurance (72.9%); - life and health reinsurance (27.1%). Gross written premiums are distributed geographically as follows: German ...
Capitalization | 31 109 M USD |
---|---|
Change | -0.15% |
1-year price change | +10.12% |
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals an ...
Capitalization | 224 B USD |
---|---|
Change | +0.11% |
1-year price change | +6.04% |
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals an ...
Capitalization | 224 B USD |
---|---|
Change | +0.98% |
1-year price change | +2.66% |
Talanx AG (Talanx) is a Germany-based provider of insurance and reinsurance products and services. The Company's activities are divided into five segments: Retail Germany, Retail International, Industrial Lines, Non-Life Reinsurance, and Life/Health Reins ...
Capitalization | 20 001 M USD |
---|---|
Change | -0.14% |
1-year price change | +10.44% |
Alnylam Pharmaceuticals, Inc. is a clinical-stage company. The Company is engaged in developing mRNA cell therapies for the treatment of autoimmune diseases. The Companyâs lead product candidate, Descartes-08, is an autologous mRNA CAR-T directed agains ...
Capitalization | 32 605 M USD |
---|---|
Change | +0.08% |
1-year price change | +34.85% |
Charles River Laboratories International, Inc. specializes in the development of products and services in the field of research and non-clinical drug development for pharmaceutical companies, government agencies and academic institutions. Net sales break ...
Capitalization | 10 442 M USD |
---|---|
Change | +4.49% |
1-year price change | -10.80% |
Tongwei Co., Ltd. is a diversified company. Net sales (before elimination of intragroup sales) are divided as follows: - production of photovoltaic cells and modules (35.7%); - production of animal feeds (35.2%): in particular, feeds for fish, pigs and ...
Capitalization | 10 383 M USD |
---|---|
Change | +2.19% |
1-year price change | -32.96% |
Lonza Group AG is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - bio-pharmaceuticals (55.4%): exclusive syntheses, microbiological fermenta ...
Capitalization | 40 959 M USD |
---|---|
Change | +2.35% |
1-year price change | +47.24% |
Focus Media Information Technology Co. Ltd. specializes in the manufacturing and marketing of computers, computer peripherals and digital communication equipment. The group also offers cell phone software and develops electronic products trading activity. ...
Capitalization | 11 949 M USD |
---|---|
Change | -0.99% |
1-year price change | -4.75% |
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell ...
Capitalization | 19 619 M USD |
---|---|
Change | +2.71% |
1-year price change | -20.66% |
CHINA TOWER CORPORATION LIMITED is a China-based telecommunications tower infrastructure service provider. The Company mainly has three business segments. The Tower Business segment mainly uses sites to carry out macro cell and small cell businesses with ...
Capitalization | 22 984 M USD |
---|---|
Change | +0.98% |
1-year price change | +25.61% |
Natera, Inc. is a diagnostics company, which is focused on the development and commercialization of molecular testing services, applying its technology in the fields of womenâs health, oncology and organ health. Its cell-free deoxyribonucleic acid (cfDN ...
Capitalization | 13 702 M USD |
---|---|
Change | +0.37% |
1-year price change | +79.57% |
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in development, manufacture and distribution of biological products. The Company, as a contract manufacturing organization (CMO), mainly develops and manufactures antibody drugs used for ...
Capitalization | 41 542 M USD |
---|---|
Change | +1.38% |
1-year price change | +6.18% |
Longi Green Energy Technology Co, Ltd. specialises in the manufacture and distribution of photovoltaic panels and solar energy products (monocrystalline silicon panels, ingots and wafers, semiconductor materials, solar cells, etc.). In addition, the group ...
Capitalization | 14 123 M USD |
---|---|
Change | +3.04% |
1-year price change | -40.79% |
Vantage Towers AG is a Germany-based wireless telecommunications carrier company. The Company builds, operates and lease passive infrastructure such as: towers, masts, rooftop sites, Distributed Antenna Systems (DAS) and Small Cells. The Company's network ...
Capitalization | 20 559 M USD |
---|---|
Change | 0.00% |
1-year price change | +1.62% |
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufa ...
Capitalization | 15 509 M USD |
---|---|
Change | +4.70% |
1-year price change | -27.55% |
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufa ...
Capitalization | 15 509 M USD |
---|---|
Change | +5.24% |
1-year price change | -26.56% |
Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solution ...
Capitalization | 19 266 M USD |
---|---|
Change | +1.45% |
1-year price change | 0.00% |
TCL Technology Group Corporation (formerly TCL Corporation) specializes in the design, manufacturing and marketing of general public telecommunications and electronic equipment. Net sales break down by activity as follows: - manufacturing and sale of sem ...
Capitalization | 10 460 M USD |
---|---|
Change | +3.23% |
1-year price change | -3.49% |
Jinko Solar Co Ltd, formerly JinkoSolar Co Ltd, is a China-based company mainly engaged in the production and sales of photovoltaic materials. The Company is mainly engaged in the research, development, processing, manufacturing, installation and sales of ...
Capitalization | 9 956 M USD |
---|---|
Change | -0.28% |
1-year price change | -18.28% |
Hanmi Semicondu-ctor Co., Ltd. is a Korea-based company mainly engaged in the manufacture of semiconductor equipment. The Company operates in two business segments: equipment segment and imported automobile segment. Its equipment segment manufactures semi ...
Capitalization | 11 332 M USD |
---|---|
Change | -1.04% |
1-year price change | +163.21% |
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sale ...
Capitalization | 11 357 M USD |
---|---|
Change | +3.99% |
1-year price change | -2.97% |
Bharat Electronics Limited is an India-based company, which manufactures and supplies electronic equipment and systems for the defense sector as well as for non-defense markets. It manufactures electronic products and systems for the army, navy, and the a ...
Capitalization | 29 213 M USD |
---|---|
Change | +0.55% |
1-year price change | +82.27% |
Grupo Elektra SAB de CV (Elektra) is a Mexico-based company primarily engaged in the banking and retailing sector. The Company is a financial services and specialty retailing company in Mexico and Central and South America, as well as a short-term non-ban ...
Capitalization | 13 077 M USD |
---|---|
Change | +0.09% |
1-year price change | -10.33% |
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net s ...
Capitalization | 14 395 M USD |
---|---|
Change | +0.75% |
1-year price change | -48.41% |
JA Solar Technology Co Ltd is a China-based company mainly engaged in the research and development, production and sales of silicon wafers, solar cells and solar modules. The Company is also engaged in the development, construction and operation of solar ...
Capitalization | 4 530 M USD |
---|---|
Change | +1.42% |
1-year price change | -51.64% |
ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company's technology comprises an antibody t ...
Capitalization | 8 359 M USD |
---|---|
Change | -.--% |
1-year price change | +5.33% |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...
Capitalization | 8 626 M USD |
---|---|
Change | +3.77% |
1-year price change | -19.28% |
Xinjiang Daqo New Energy Co Ltd is a China-based company principally engaged in the research and development, manufacturing and sales of high-purity polysilicon. The Company's main product is polysilicon. The Company's products are mainly used in the prod ...
Capitalization | 5 522 M USD |
---|---|
Change | +1.08% |
1-year price change | -36.42% |
Hannover House, Inc. is a media production and distribution company. The Company is involved in book publishing, feature film and video production, and distribution of feature films and videos through various media platforms and territories worldwide. It ...
Capitalization | 5 M USD |
---|---|
Change | +9.62% |
1-year price change | 0.00% |
SUMCO Corporation specializes in the production and marketing of silicon wafers. The products are intended in particular for the manufacture of semiconductor components and photovoltaic cells. At the end of 2020, the group had 7 production sites located ...
Capitalization | 5 398 M USD |
---|---|
Change | +5.89% |
1-year price change | +25.02% |
Doosan Enerbility, formerly Doosan Heavy Industries & Construction Co Ltd, is a Korea-based company principally engaged in the industrial equipment manufacture business. The Company operates its business through six segments. The Doosan Bobcat Business se ...
Capitalization | 10 121 M USD |
---|---|
Change | -1.80% |
1-year price change | +37.42% |
Suzhou Maxwell Technologies Co., Ltd. is a China-based company principally engaged in the design, development, production and sales of intelligent manufacturing equipment. The Company's main products are solar cell screen printing production line complete ...
Capitalization | 4 042 M USD |
---|---|
Change | -1.02% |
1-year price change | -18.52% |
San'an Optoelectronics Co., Ltd. specializes in the development, production, and marketing of LED epitaxial products, chips, compound solar cells, sapphire substrates, and high-power concentrating solar products. The products are used in indoor and outdoo ...
Capitalization | 8 036 M USD |
---|---|
Change | +0.68% |
1-year price change | -14.73% |
Tradegate AG Wertpapierhandelsbank is a Germany-based order book manager and provider of a wide range of financial services. The Company focuses on trading of domestic and foreign securities and also offers traditional retail banking services. It operates ...
Capitalization | 2 825 M USD |
---|---|
Change | 0.00% |
1-year price change | -1.83% |
alstria office REIT AG is a Germany-based real estate investment trust (REIT) that focuses on acquiring, owning and managing office real estate in Germany. The Companyâs real estate operations cover asset management, property and technical management, a ...
Capitalization | 675 M USD |
---|---|
Change | -1.86% |
1-year price change | -4.64% |
MTN Group Limited is one of the leading South African mobile telecommunication operators. Net sales break down by activity as follows: - mobile telecommunication services (92%); - sale of cell phones and accessories (5.4%); - other (2.6%). Net sales ...
Capitalization | 8 169 M USD |
---|---|
Change | -0.18% |
1-year price change | -29.01% |
CAPCOM CO., LTD. mainly engages in digital contents business, amusement facility business and others. The Company operates in three segments. The Digital Contents segment develops and sells household games and online games, and contents for cell phones. T ...
Capitalization | 8 322 M USD |
---|---|
Change | +2.45% |
1-year price change | +44.73% |
INVENTEC CORPORATION is a Taiwan-based company principally engaged in the research and development, manufacture and sales of computer products. The Company's main products include portable notebook computers, business computers, servers, storage devices, ...
Capitalization | 6 266 M USD |
---|---|
Change | +1.79% |
1-year price change | +7.95% |
Tianjin Zhonghuan Semiconductor Co., Ltd. (TJSEMI) specializes in the manufacturing and marketing of integrated semiconductor devices for solar energy saving industry. Net sales break down by activity as follows: - manufacturing of semiconductor material ...
Capitalization | 4 568 M USD |
---|---|
Change | +4.05% |
1-year price change | -47.38% |
mwb Fairtrade Wertpapierhandelsbank AG is a Germany-based securities trading bank. The Company operates in two segments: Securities Trading and Capital Markets. The Securities Trading segment encompasses order-book management for equities, order-book mana ...
Capitalization | 32 M USD |
---|---|
Change | 0.00% |
1-year price change | +44.00% |
United Fidelity Insurance Company PSC, formerly United Insurance Co PSC, is a United Arab Emirates-based company, which is engaged in the provision of general insurance services. The Company is organized into two business segments: the General Insurance s ...
Capitalization | 70 M USD |
---|---|
Change | -1.99% |
1-year price change | -.--% |
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; ...
Capitalization | 6 758 M USD |
---|---|
Change | +6.06% |
1-year price change | -28.98% |
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule ...
Capitalization | 6 394 M USD |
---|---|
Change | +0.99% |
1-year price change | +216.06% |
Innovent Biologics Inc is an investment holding company principally engaged in biopharmaceuticals. The Company and its subsidiaries are engaged in research and development of antibody and protein medicine products, sale and distribution of pharmaceutical ...
Capitalization | 7 526 M USD |
---|---|
Change | +6.23% |
1-year price change | -10.29% |
UL Solutions Inc. is a global safety science company. The Company provides independent testing, inspection and certification (TIC) services and related software and advisory (S&A) offerings to customers worldwide. Its segments include Industrial, Consumer ...
Capitalization | 8 720 M USD |
---|---|
Change | +1.96% |
1-year price change | 0.00% |
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bi ...
Capitalization | 5 819 M USD |
---|---|
Change | +3.56% |
1-year price change | +230.46% |
Exelixis, Inc. is an oncology company. The Company is engaged in developing medicines and combination regimens at the forefront of cancer care. It has produced four marketed pharmaceutical products, two of which are formulations of its flagship molecule, ...
Capitalization | 6 423 M USD |
---|---|
Change | +1.95% |
1-year price change | -6.61% |
Donaldson Company, Inc. provides technology-led filtration products and solutions, serving a range of industries and advanced markets. The Company operates in three segments: Mobile Solutions, Industrial Products, and Life Sciences. The Mobile Solutions s ...
Capitalization | 8 480 M USD |
---|---|
Change | +2.29% |
1-year price change | +9.82% |
WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly ...
Capitalization | 5 666 M USD |
---|---|
Change | +4.32% |
1-year price change | -62.43% |
Bio-Rad Laboratories, Inc. is specialized in the development, manufacturing and marketing of products used in life sciences research, clinical diagnostics and analytical chemistry. Net sales break down by activity as follows: - manufacture of clinical di ...
Capitalization | 8 013 M USD |
---|---|
Change | +4.02% |
1-year price change | -10.08% |
Vaxcyte Inc. is a clinical-stage vaccine company. It is engaged in developing a spectrum conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its lead candidate, VAX-24, is a Phase III-ready 24-valent, carrier-sparing pneumoco ...
Capitalization | 8 810 M USD |
---|---|
Change | +2.39% |
1-year price change | +32.09% |
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritin ...
Capitalization | 7 260 M USD |
---|---|
Change | +0.94% |
1-year price change | +26.90% |
Arab Assurers Insurance Co PSC, formerly Arab Assurers Co PLC, is a Jordan-based public shareholding company that provides all classes of life and non-life insurance products and services. The Company is organized into two business segment: General Insura ...
Capitalization | 2 M USD |
---|---|
Change | +5.88% |
1-year price change | -.--% |
Pell Bio Med Technology Co Ltd is a Taiwan-based trading company mainly engaged in the immune genetic engineering and the development of non-genetically modified cell therapy products and non-cell products. The main business focuses on immune cell therapy ...
Capitalization | 226 M USD |
---|---|
Change | 0.00% |
1-year price change | 0.00% |
Albis Leasing AG is a Germany-based provider of leasing services. The Company operates through two segments: Leasing of Investment Products and Distribution Leasing. The Leasing of Investment Products segment comprises ALBIS Mobil Lease GmbH und die UTA L ...
Capitalization | 55 M USD |
---|---|
Change | +2.56% |
1-year price change | +20.60% |
Cell Source, Inc. is a cell therapy company focused on immunotherapy. The Company is primarily focused on the development of immune system management technology (Veto Cell technology). Its lead prospective product is its Veto Cell immune system management ...
Capitalization | 32 815 USD |
---|---|
Change | +300.00% |
1-year price change | -99.83% |
Unicocell Biomed Co Ltd is mainly engaged in the research and development of new adipose stem cell drugs and the application of stem cell technology. The main products include stem cell secretin and cell testing services. The Company's current development ...
Capitalization | 143 M USD |
---|---|
Change | -0.37% |
1-year price change | -3.73% |
Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patientâs blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and ...
Capitalization | 3 M USD |
---|---|
Change | +11.11% |
1-year price change | -28.57% |
DuoGenic StemCells Corp is a Taiwan-based company mainly engaged in the provision of cell separator set and stem cell culture media. The culture medium provides the nutrients and raw materials needed for cell growth and reproduction. The cell separator se ...
Capitalization | 30 M USD |
---|---|
Change | -4.62% |
1-year price change | -11.11% |
Cell Kinetics Limited is seeking to commercially exploit a growing need to study individual live cells, through the development, marketing and selling of an improved Cell carrier under the CKChip product line. The Cell Carrier can accommodate cells, each ...
Capitalization | 1 999 USD |
---|---|
Change | -.--% |
1-year price change | -.--% |
Advent Technologies Holdings, Inc. is an advanced materials and technology development company operating in the fuel cell and hydrogen technology space. The Company develops, manufactures, and assembles complete fuel cell systems and the critical componen ...
Capitalization | 10 M USD |
---|---|
Change | -1.04% |
1-year price change | -43.00% |
Meribank Biotech Co Ltd is a Taiwan-based company mainly engaged in the stem cell storage business. The Company is engaged in the provision of cord blood (hematopoietic stem cells) storage and application services, placenta and umbilical cord (mesenchymal ...
Capitalization | 95 M USD |
---|---|
Change | -1.13% |
1-year price change | +14.83% |
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the ...
Capitalization | 3 M USD |
---|---|
Change | +18.28% |
1-year price change | -73.41% |
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company ...
Capitalization | 66 M USD |
---|---|
Change | -1.67% |
1-year price change | -57.86% |
Gwo Xi Stem Cell Applied Technology Co Ltd is a Taiwan-based company mainly engaged in the development of stem cell drugs and technologies for the treatment of refractory diseases. The Company owns the Medical-Grade Cell Preparation Platform for the colle ...
Capitalization | 110 M USD |
---|---|
Change | -0.40% |
1-year price change | +3.44% |
SanBio Co Ltd is engaged in the regenerative cell business using allogeneic stem cells. The Company has the research and development base in the United States and conducts research, development, manufacture and sale of regenerative cell medicines in Japan ...
Capitalization | 462 M USD |
---|---|
Change | +0.92% |
1-year price change | +56.41% |
Magenta Therapeutics, Inc. is a biotechnology company focused on improving stem cell transplantation. The Company is developing medicines designed to bring the curative power of stem cell transplants to more patients with blood cancers, genetic diseases, ...
Capitalization | 676 M USD |
---|---|
Change | +1.48% |
1-year price change | +159.66% |
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprieta ...
Capitalization | 355 M USD |
---|---|
Change | +8.65% |
1-year price change | -10.16% |
Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-bas ...
Capitalization | 36 M USD |
---|---|
Change | +0.26% |
1-year price change | -26.56% |
ViGenCell Inc is a Korea-based company principally engaged in the development of cell therapy business. The Company is engaged in the development and manufacture of immuno-cancer cell therapy products and immunosuppressive cell therapy products. In additi ...
Capitalization | 49 M USD |
---|---|
Change | +0.43% |
1-year price change | -39.91% |
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (in ...
Capitalization | 76 M USD |
---|---|
Change | +2.17% |
1-year price change | -19.43% |
S-Fuelcell Co,. LTD. is a Korea-based company mainly engaged in the production and sale of fuel cell systems for buildings. The Fuel cell systems for buildings include modular, standard fuel cell systems and hydrogen generation systems. The Company provid ...
Capitalization | 75 M USD |
---|---|
Change | -0.07% |
1-year price change | -12.43% |
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. Its engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy ca ...
Capitalization | 304 M USD |
---|---|
Change | +5.46% |
1-year price change | +58.89% |
Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment international ...
Capitalization | 535 989 USD |
---|---|
Change | +7.25% |
1-year price change | +487.67% |
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using ...
Capitalization | 1 046 M USD |
---|---|
Change | +5.09% |
1-year price change | -34.32% |
MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iN ...
Capitalization | 34 M USD |
---|---|
Change | +8.97% |
1-year price change | -11.40% |
CARGO Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in advancing curative cell therapies for cancer patients. Its programs, platform technologies, and manufacturing strategy are designed to directly address the chime ...
Capitalization | 761 M USD |
---|---|
Change | +3.83% |
1-year price change | -25.79% |
MaxCyte, Inc. is a commercial cell engineering company. The Company is focused on providing enabling platform technologies to advance the discovery, development and commercialization of cell therapeutics, including cell and gene therapies, and to support ...
Capitalization | 432 M USD |
---|---|
Change | -0.86% |
1-year price change | -9.72% |
Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company is focused on development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. It is focused on four core p ...
Capitalization | 499 M USD |
---|---|
Change | +8.79% |
1-year price change | -19.00% |
Bumhan Fuel Cell Co Ltd is a Korea-based company principally engaged in the development and production of hydrogen fuel cells. The Company operates its business through two segments. The Fuel Cell segment is engaged in the production and sale of fuel cell ...
Capitalization | 126 M USD |
---|---|
Change | 0.00% |
1-year price change | +0.25% |
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs. The Companyâs programs are based on its cell-based technology platform and associated development and manufacturing c ...
Capitalization | 181 M USD |
---|---|
Change | +5.65% |
1-year price change | -6.88% |
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments ...
Capitalization | 724 M USD |
---|---|
Change | +6.12% |
1-year price change | -79.62% |
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. ...
Capitalization | 3 M USD |
---|---|
Change | +4.99% |
1-year price change | -4.89% |
Kadimastem Ltd is an Israel-based regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders. The Companyâs technology enables the dif ...
Capitalization | 9 M USD |
---|---|
Change | -9.39% |
1-year price change | +16.80% |
Vectorite Biomedical Inc is a Taiwan-based company mainly engaged in providing cell product commissioned production services and cell preparations. Products include dendritic cell (DC) vaccines, and natural killer (NK) cell preparations for cancer treatme ...
Capitalization | 24 M USD |
---|---|
Change | -1.94% |
1-year price change | -17.33% |
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services ...
Capitalization | 70 M USD |
---|---|
Change | 0.00% |
1-year price change | +2.33% |
Better Capital PCC Limited is a closed-ended investment company. The Company acts as Protected Cell Company, and also acts as a feeder fund, through each cell, and pursues an investment objective, which aims to generate total returns by investing in a por ...
Capitalization | 4 M USD |
---|---|
Change | +0.10% |
1-year price change | -86.67% |
Century Therapeutics, Inc. is a biotechnology company. The Company is focused on developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with unmet medical need. The Compa ...
Capitalization | 199 M USD |
---|---|
Change | +6.36% |
1-year price change | -24.40% |
Celularity Inc. is a clinical-stage biotechnology company. The Company is engaged in developing off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through three business se ...
Capitalization | 61 M USD |
---|---|
Change | +0.71% |
1-year price change | +14.80% |
Acepodia Inc is engaged in the research and development of new anti-cancer drugs. The Company uses antibody-cell conjugation (ACC) and immune cells. The products include Gamma delta 2T cell platform including ACE1831 (ACE-gdT-CD20) an antibody linked to s ...
Capitalization | 435 M USD |
---|---|
Change | +0.40% |
1-year price change | -27.09% |
K Pharma Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through a single segment of research, development, manufacture, and sale of pharmaceuticals, among others. The Company is engaged in induced pluripot ...
Capitalization | 58 M USD |
---|---|
Change | -0.37% |
1-year price change | +10.97% |
U.S. Stem Cell, Inc. is a biotechnology company. The Company is focused on the discovery, development and subject to regulatory approval and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. The Company's ...
Capitalization | 66 150 USD |
---|---|
Change | +9,900.00% |
1-year price change | +9,900.00% |
PharmaCyte Biotech, Inc. is a biotechnology company. It is focused on developing cellular therapies for cancer, diabetes, and malignant ascites based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Its product candidate i ...
Capitalization | 17 M USD |
---|---|
Change | +0.00% |
1-year price change | -4.62% |
Eterna Therapeutics Inc. is a life science company committed to realizing the potential of messenger ribonucleic acid (RNA) (mRNA) cell engineering to provide patients with transformational new medicines. The Company has in-licensed a portfolio of over 10 ...
Capitalization | 10 M USD |
---|---|
Change | +2.19% |
1-year price change | +4.18% |
Pathfinder Cell Therapy, Inc. is a regenerative medicine company. The Company is seeking to develop cell-based and related therapies for the treatment of a range of diseases and medical conditions characterized by organ-specific cell damage. The Company i ...
Capitalization | 667 USD |
---|---|
Change | -.--% |
1-year price change | -.--% |
BrainStorm Cell Therapeutics Inc. is a developer of autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The neurodegenerative diseases include Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis (PMS), Alzh ...
Capitalization | 28 M USD |
---|---|
Change | +12.54% |
1-year price change | +42.86% |
TC BioPharm Limited is a clinical-stage cell therapy company. The Company is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infecti ...
Capitalization | 4 M USD |
---|---|
Change | -0.05% |
1-year price change | -73.17% |
Solid Power, Inc. is a developer of solid-state battery technology. The Company is focused on producing and distributing sulfide-based solid electrolyte material for powering both electric vehicles (EVs) and other applications. The Company's technology is ...
Capitalization | 315 M USD |
---|---|
Change | +13.20% |
1-year price change | +37.94% |